Biocon Biologics is proud to collaborate with Direct Relief to help provide life-saving, affordable biosimilars to patients in need. We recently completed our first donation of insulin glargine and trastuzumab to benefit underserved patients impacted by cancer and diabetes. #Diabetes #Cancer #Biosimilars #BioconBiologics
Direct Relief is thrilled to announce that global biosimilars company Biocon Biologics has joined forces as its latest pharmaceutical donation partner. Biocon Biologics’ initial donation consisted of long-acting analogue insulin glargine and the cancer injectable monoclonal antibody trastuzumab biosimilar medicine, both of which require cold-chain storage, handling, and transport. Direct Relief and Biocon Biologics are committed to making life-saving medications more accessible to underserved populations in lower-income countries. Direct Relief has shipped over 3,000 cold-chain shipments this Fiscal Year and the organization utilizes modern digital technology to ensure that the donated medicines maintain their integrity. Direct Relief is so thankful to the Biocon Biologics team for their tremendous collaboration and support. Stay tuned for more updates on this impactful journey and join Direct Relief in celebrating this milestone towards a healthier future for all. #BioconBiologics #DirectRelief #PartnershipForChange #HealthEquityForAll
Head, North America Supply Chain Management
2wIt's an honor to be working with an amazing team at Direct Relief and thank you for all you do!